Stéphane Bancel
Tracked across 5 events · 684 articles · First seen May 29, 2025 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Impact: Stéphane Bancel, CEO of Moderna, expressed appreciation for the United States — Food and Drug Administration's engagement and agreement to review the vaccine, highlighting the company's goal to make the flu vaccine available to seniors.
Feb 18, 2026 · 9 articles
International
A severe Ebola outbreak, caused by the rare Bundibugyo strain, is rapidly spreading in the Democratic Republic of the Congo, primarily in Democratic Republic of the Congo — Ituri Province, with cases also confirmed in…
Impact: Stéphane Bancel, CEO of Moderna, pledged urgency and scientific rigor in developing a Bundibugyo vaccine.
May 21, 2026 · 627 articles
Tech
Global health organizations are accelerating efforts to develop vaccines against the Ebola Bundibugyo strain, which is causing an outbreak in Democratic Republic of the Congo and Uganda. The Coalition for Epidemic Preparedness Innovations (CEPI) has…
Impact: Stéphane Bancel>>>, CEO of Moderna>>>, expressed pride in the expanded collaboration, highlighting Moderna's>>> commitment to rapid response to infectious disease threats.
May 22, 2026 · 36 articles
Regulatory
Impact: Stéphane Bancel, CEO of Moderna, expressed disappointment over the funding termination but highlighted the positive interim results of the vaccine trial and the company's intent to explore alternative funding.
May 29, 2025 · 6 articles
Regulatory
Impact: Stéphane Bancel, Moderna's CEO, expressed disappointment with the United States — Food and Drug Administration's decision, stating it does not further shared goals of innovation.
Feb 10, 2026 · 6 articles
NEWSDESK
Track Stéphane Bancel live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard